Clinical trial NCT05324449
Status: Completed, results awaitedPhase 4Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Epidiolex® for Anxiety in Pediatric Epilepsy
- Record number
- NCT05324449
- Status
- Completed, results awaited
- Type and phase
- Clinical trial, phase 4
- Participants
- 20 (actual)
- Condition (as registered)
- Anxiety, Epilepsy
- Countries
- United States
- Topic in the guide
- Drug-Resistant Epilepsy, Anxiety
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: April 5, 2022
- End of data collection for primary results: March 17, 2025
- Trial completion: May 5, 2025
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Completed, results awaited.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Drug-Resistant Epilepsy: ongoing trials · Anxiety: ongoing trials · Thinking of taking part? Which specialist to see